Bioorthogonal reactions have been widely used in the biomedical field. 18F‐TCO/Tetrazine ligation is the most reactive radiolabelled inverse electron demand Diels–Alder reaction, but its application had been limited due to modest contrast ratios of the resulting conjugates. Herein, we describe the use of hydrophilic tetrazines to improve tumor‐to‐background contrast of neurotensin receptor targeted PET agents. PET agents were constructed using a rapid Diels–Alder reaction of the radiolabeled trans‐cyclooctene (18F‐sTCO) with neurotensin (NT) conjugates of a 3,6‐diaryltetrazine, 3‐methyl‐6‐aryltetrazine, and a derivative of 3,6‐di(2‐hydroxyethyl)tetrazine. Although cell binding assays demonstrated all agents have comparable binding affinity, the conjugate derived from 3,6‐di(2‐hydroxyethyl)tetrazine demonstrated the highest tumor to muscle contrast, followed by conjugates of the 3‐methyl‐6‐aryltetrazine and 3,6‐diaryltetrazine.